Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 103,916 | 64,953 | 51,754 | 54,193 | 63,461 |
| Operating Income | -103,916 | -64,953 | -51,754 | -54,193 | -63,461 |
| Other Income | -9,253 | 1,799 | -3,590 | -466 | -4,914 |
| Pre-tax Income | -113,169 | -63,154 | -55,344 | -54,659 | -68,375 |
| Income Tax | -605 | 108 | -360 | -159 | 17 |
| Net Income Continuous | -112,564 | -63,262 | -54,984 | -54,500 | -68,392 |
| Minority Interests | -37 | -43 | -13 | -99 | -35 |
| Net Income | $-112,527 | $-63,219 | $-54,971 | $-54,401 | $-68,357 |
| EPS Basic Total Ops | -1.85 | -1.07 | -0.87 | -0.96 | -1.34 |
| EPS Basic Continuous Ops | -1.85 | -1.07 | -0.88 | -0.96 | -1.34 |
| EPS Diluted Total Ops | -1.85 | -1.07 | -0.87 | -0.96 | -1.34 |
| EPS Diluted Continuous Ops | -1.85 | -1.07 | -0.88 | -0.96 | -1.34 |
| EBITDA(a) | $-106,794 | $-67,854 | $-53,871 | $-55,084 | $-63,242 |